{"id":"W4307160114","doi":"10.1053/j.seminoncol.2022.10.001","title":"IO-IO vs IO-TKI efficacy in metastatic kidney cancer patients: A structured systematic review over time","year":2022,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Nivolumab; Internal medicine; Ipilimumab; Cabozantinib; Pembrolizumab; Axitinib; Sunitinib; Renal cell carcinoma; Oncology; Kidney cancer; Hazard ratio; Clinical trial; Progression-free survival; Cancer; Immunotherapy; Overall survival; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001255693,0.001003412,0.009685561,0.000821228,0.00005706439,0.00001345573,0.0005574027,0.0004446365,0.004797931],"category_scores_gemma":[0.002687816,0.000744077,0.0008706896,0.001380703,0.0001193369,0.00005509137,0.0003353418,0.001422353,0.000209797],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.009335198,"about_ca_system_score_gemma":0.002590041,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001862225,"about_ca_topic_score_gemma":0.00006889077,"domain_scores_codex":[0.9919055,0.002643328,0.002781434,0.001090821,0.0007899886,0.0007889896],"domain_scores_gemma":[0.9949992,0.00177896,0.001580819,0.001172864,0.00008518705,0.0003829872],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009711296,0.00112353,0.00009796346,0.8730202,0.0007563193,0.002333585,0.0002931154,0.000001376892,4.744307e-7,0.000008534948,0.01382115,0.1084467],"study_design_scores_gemma":[0.002032413,0.001183576,0.00005244283,0.4765394,0.008678575,0.0003487125,0.00001353527,0.000004401163,3.784572e-7,0.0000100369,0.5107519,0.000384615],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002953889,0.9844828,1.098093e-7,0.0002024522,0.0007051092,0.01274281,0.0002472326,0.00004051521,0.001283609],"genre_scores_gemma":[0.00002153014,0.9883494,0.0002108649,0.001685251,0.00008438656,0.005911049,0.001657212,0.0001629059,0.001917384],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.4969307,"threshold_uncertainty_score":0.999501,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03645426860760719,"score_gpt":0.3739355171632866,"score_spread":0.3374812485556794,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}